Frontlight ResearchEarly access
Trial site
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
- 13running trials
- 3closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer3 trials
- Gastric and oesophageal cancer3 trials
- Heart failure2 trials
- Neuroendocrine tumours2 trials
- Ovarian cancer2 trials
- Prostate cancer2 trials
- Aortic stenosis1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- and 3 more
- Phase
- Phase 35 trials
- Phase 24 trials
- Phase 1/23 trials
- Phase 12 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting10 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- Boehringer Ingelheim3 trials
- AbbVie1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Bristol Myers Squibb International Corporation1 trial
- Eikon Therapeutics1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Neuroendocrine tumours2 recruiting
- Prostate cancer2 recruiting
- Aortic stenosis1 recruiting
- Childhood cancers1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
Active, not recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026